Computational analysis of eugenol inhibitory activity in lipoxygenase and cyclooxygenase pathways

Francisco das Chagas Pereira de Andrade1,2, Anderson Nogueira Mendes3,4

  • 1Laboratory of Innovation in Science and Technology - LACITEC, Department of Biophysics and Physiology, Federal University of Piauí, Teresina, Piauí, 64049-550, Brazil.

Scientific Reports
|October 2, 2020
PubMed

Insights

Eugenol shows potential as a natural anti-inflammatory agent, with computational analysis revealing pharmacokinetic properties similar to NSAIDs and the ability to inhibit key inflammatory enzymes like COX-2 and 5-LOX.

Area of Science:

  • Computational chemistry
  • Pharmacology
  • Natural product chemistry

Background:

  • Chronic inflammation underlies diseases like osteoarthritis, Crohn's disease, and cancer.
  • Controlling pro-inflammatory processes is crucial for disease management.
  • Anti-inflammatory drugs are key therapeutic agents, but often have side effects.

Purpose of the Study:

  • To computationally analyze eugenol's anti-inflammatory potential.
  • To compare eugenol's ADMET profile with aspirin and diclofenac.
  • To investigate eugenol's interaction with cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) enzymes.

Main Methods:

  • In silico ADMET profiling of eugenol.
  • Bioinformatics coupling tests to assess enzyme binding.
  • Comparative analysis with established non-steroidal anti-inflammatory drugs (NSAIDs).

Main Results:

  • Eugenol's in silico pharmacokinetic profile resembles that of NSAIDs like aspirin and diclofenac.
  • Bioinformatics analysis indicates eugenol can bind to both COX-2 and 5-LOX enzymes.
  • These findings align with literature suggesting eugenol's anti-inflammatory activity with fewer side effects.

Conclusions:

  • Eugenol exhibits favorable ADMET properties and enzyme-binding capabilities relevant to inflammation.
  • Computational results support eugenol as a potential natural anti-inflammatory compound.
  • Eugenol may offer an alternative to NSAIDs for managing inflammatory conditions with reduced gastrointestinal risks.

Related Concept Videos

Oxidation of Alkenes: Syn Dihydroxylation with Osmium Tetraoxide02:44

Oxidation of Alkenes: Syn Dihydroxylation with Osmium Tetraoxide

Alkenes are converted to 1,2-diols or glycols through a process called dihydroxylation. It involves the addition of two hydroxyl groups across the double bond with two different stereochemical approaches, namely anti and syn. Dihydroxylation using osmium tetroxide progresses with syn stereochemistry.
12.2K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
89.5K
Radical Autoxidation01:20

Radical Autoxidation

The oxidation of an organic compound in the presence of air or oxygen is called autoxidation. For example, cumene reacts with oxygen to form hydroperoxide. Autoxidation involves initiation, propagation, and termination steps. Many organic compounds are susceptible to autoxidation—especially ethers in the presence of oxygen, which form hydroperoxides. Even though this reaction is slow, old ether bottles contain small amounts of peroxide, which leads to laboratory explosions during ether...
2.8K
Oxidation of Alkenes: Anti Dihydroxylation with Peroxy Acids02:04

Oxidation of Alkenes: Anti Dihydroxylation with Peroxy Acids

Diols are compounds with two hydroxyl groups. In addition to syn dihydroxylation, diols can also be synthesized through the process of anti dihydroxylation. The process involves treating an alkene with a peroxycarboxylic acid to form an epoxide. Epoxides are highly strained three-membered rings with oxygen and two carbons occupying the corners of an equilateral triangle. This step is followed by ring-opening of the epoxide in the presence of an aqueous acid to give a trans diol.
6.9K
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems01:19

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
551
Oxidative Cleavage of Alkenes: Ozonolysis01:46

Oxidative Cleavage of Alkenes: Ozonolysis

In ozonolysis, ozone is used to cleave a carbon–carbon double bond to form aldehydes and ketones, or carboxylic acids, depending on the work-up.
Ozone is a symmetrical bent molecule stabilized by a resonance structure.
12.4K